Health Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in foreign ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

A groundbreaking SAMRC study has uncovered significant underreporting of HIV-related deaths in South Africa, despite the ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...

in adults with HIV-1/HBV coinfection initiating treatment. Previously reported results demonstrated the efficacy of both antiretroviral regimens. The newly presented data shows that Biktarvy ...